Aviva
ARNA

Aviva’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Aviva’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,919
Closed -$1.17M – 1014
2021
Q1 		$1.17M Sell
16,919
-142
-0.8% -$10.9K 0.01% 877
2020
Q4 		$1.31M Sell
17,061
-13,832
-45% -$1.04M 0.01% 814
2020
Q3 		$2.31M Sell
30,893
-5,492
-15% -$366K 0.01% 681
2020
Q2 		$2.29M Sell
36,385
-49,708
-58% -$2.74M 0.01% 708
2020
Q1 		$3.62M Buy
86,093
+45,246
+111% +$2.07M 0.03% 576
2019
Q4 		$1.85M Buy
+40,847
New +$1.93M 0.01% 808

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aviva's ARNA Position: Q2 2021 in Review

Aviva sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 16,919 shares — an estimated $1.17M sold.

Aviva first reported a position in ARNA in Q4 2019 and held it in 6 quarters. The position peaked at $3.62M in Q1 2020. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

  • Aviva reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Aviva sold 16,919 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $1.17M.
  • Aviva first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 6 quarters.
  • Aviva's Arena Pharmaceuticals Inc position peaked at $3.62M in Q1 2020.
  • 237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.